Cargando…

Mirtazapine for the Treatment of Chronic Pruritus

Background: Chronic pruritus is a debilitating condition associated with a wide range of dermatologic, systemic and psychogenic etiologies. In patients with chronic pruritus that is refractory to conventional therapy, symptoms can significantly decrease quality of life by contributing to anxiety, sl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanna, Raveena, Boozalis, Emily, Belzberg, Micah, Zampella, John G., Kwatra, Shawn G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789675/ https://www.ncbi.nlm.nih.gov/pubmed/31284577 http://dx.doi.org/10.3390/medicines6030073

Ejemplares similares

Association between Itch and Cancer in 3836 Pediatric Pruritus Patients at a Tertiary Care Center
por: Belzberg, Micah, et al.
Publicado: (2019)

Racial and Gender Differences in the Presentation of Pruritus
por: Whang, Katherine A., et al.
Publicado: (2019)

Aprepitant for the Treatment of Chronic Refractory Pruritus
por: He, Alice, et al.
Publicado: (2017)

Association between Prurigo Nodularis and Etiologies of Peripheral Neuropathy: Suggesting a Role for Neural Dysregulation in Pathogenesis
por: Hughes, John-Douglas Matthew, et al.
Publicado: (2020)

Pruritus associated with abrupt mirtazapine discontinuation: Single case report
por: Spitznogle, Brittany, et al.
Publicado: (2019)

Emerging Research in Chronic Pruritus: From Bedside to Bench and Back Again
por: Williams, Kyle A., et al.
Publicado: (2020)

Comparison of mirtazapine, gabapentin and ondansetron to prevent intrathecal morphine-induced pruritus
por: Akhan, Ayse, et al.
Publicado: (2016)

Proteomic and Phosphoproteomic Analysis Reveals that Neurokinin-1 Receptor (NK1R) Blockade with Aprepitant in Human Keratinocytes Activates a Distinct Subdomain of EGFR Signaling: Implications for the Anti-Pruritic Activity of NK1R Antagonists
por: Kwatra, Shawn G., et al.
Publicado: (2019)

Modulation of the kappa and mu opioid axis for the treatment of chronic pruritus: A review of basic science and clinical implications
por: Elmariah, Sarina, et al.
Publicado: (2022)

Differential onset time of mirtazapine on pruritus and depression in a patient receiving hemodialysis
por: Miyahara, Yu, et al.
Publicado: (2021)

Comorbidities in Mycosis Fungoides and Racial Differences in Co-Existent Lymphomatoid Papulosis: A Cross-Sectional Study of 580 Patients in an Urban Tertiary Care Center
por: Kaul, Subuhi, et al.
Publicado: (2019)

Nightmares and Mirtazapine—Time to be vigilant
por: Sudha TY, Sree, et al.
Publicado: (2020)

Diagnostic Workup and Evaluation of Patients with Prurigo Nodularis
por: Kwon, Christina D., et al.
Publicado: (2019)

A Case of Emetophobia Responding to Mirtazapine and Propranolol Treatment
por: Köksal, Merve, et al.
Publicado: (2022)

Nightmares with mirtazapine - A case report
por: Kavoor, Anjana Rao, et al.
Publicado: (2020)

Mirtazapine Induced Tremors: A Case Report
por: Uvais, N. A., et al.
Publicado: (2019)

Mirtazapine in Paroxetine Induced Hyper-prolactinemic Galactorrhoea
por: Singh, Manjeet, et al.
Publicado: (2015)

Sleep-Related Eating Disorder Associated With Mirtazapine
por: Jeong, Jong-Hyun, et al.
Publicado: (2014)

Pruritus Associated with Commonly Prescribed Medications in a Tertiary Care Center
por: Huang, Amy H., et al.
Publicado: (2019)

Mirtazapine Induced Akathisia: Understanding a Complex Mechanism
por: Raveendranathan, Dhanya, et al.
Publicado: (2015)

Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis
por: Blauvelt, Andrew, et al.
Publicado: (2022)

Pregabalin and Uremic Pruritus
por: Shubhakaran, Khichar Purnaram
Publicado: (2017)

Evaluation of Efficacy of Mirtazapine on Pruritus and Serum Histamine and Serotonin Levels in Patients Undergoing Hemodialysis: A Before–After Pilot Clinical Trial
por: Mehrpooya, Maryam, et al.
Publicado: (2020)

Mirtazapine for Refractory Gastroparesis
por: Marella, Hemnishil K., et al.
Publicado: (2019)

Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
por: Wongvibulsin, Shannon, et al.
Publicado: (2021)

Chronic dosing with mirtazapine does not produce sedation in rats
por: Salazar-Juárez, Alberto, et al.
Publicado: (2017)

Treatment for Refractory Pruritus Using Oral Aprepitant
por: Huh, Joon Won, et al.
Publicado: (2016)

Epidemiology and Comorbidities of Excoriation Disorder: A Retrospective Case-Control Study
por: Kwon, Christina, et al.
Publicado: (2020)

Validation of the Peak Pruritus Numerical Rating Scale as a Patient-Reported Outcome Measure in Prurigo Nodularis
por: Kwatra, Shawn G., et al.
Publicado: (2023)

Mirtazapine withdrawal-induced mania
por: Verma, Jitendra Kumar, et al.
Publicado: (2015)

Tachyphylaxis to the Sedative Action of Mirtazapine
por: Papazisis, Georgios, et al.
Publicado: (2018)

Mirtazapine overdose is unlikely to cause major toxicity
por: Berling, I., et al.
Publicado: (2014)

PS213. Pharmacokinetics of mirtazapine and its hydroxylated metabolite in Japanese psychiatric patients treated with mirtazapine
por: Watanabe, Takashi, et al.
Publicado: (2016)

Comorbidities Associated with Granuloma Annulare: A Cross-Sectional, Case-Control Study
por: Almazan, Erik, et al.
Publicado: (2020)

Pruritus in patients with amyopathic dermatomyositis
por: Poddighe, Dimitri, et al.
Publicado: (2019)

A study of postherpetic pruritus
por: Mittal, Asit, et al.
Publicado: (2016)

Mirtazapine in the treatment of essential tremor: an open-label, observer-blind study
por: Uccellini, Davide, et al.
Publicado: (2006)

Novel Kappa-Opioid Receptor Agonist for the Treatment of Cholestatic Pruritus: Systematic Review
por: Bailey, Adrian Joseph Michel, et al.
Publicado: (2022)

Which patients with chronic pruritus are presented for psychological assessment by their dermatologists? Results from a consecutive sample
por: Schneider, G., et al.
Publicado: (2019)

Serotonin Receptor 2C -759C/T Polymorphism and Weight Change or Treatment Response to Mirtazapine in Korean Depressive Patients
por: Pae, Chi-Un
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7c6c0ue5flheobmvqaibrm4eeq